Karine Lacombe to Female
This is a "connection" page, showing publications Karine Lacombe has written about Female.
Connection Strength
0.120
-
Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019. Clin Infect Dis. 2021 10 05; 73(7):e1762-e1765.
Score: 0.013
-
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19. Blood. 2020 11 12; 136(20):2290-2295.
Score: 0.012
-
Testing for hepatitis B virus alone does not increase vaccine coverage in non-immunized persons. World J Gastroenterol. 2017 Oct 14; 23(38):7037-7046.
Score: 0.010
-
Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients. J Clin Virol. 2017 10; 95:55-60.
Score: 0.010
-
HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study. J Int AIDS Soc. 2017 05 15; 20(1):21446.
Score: 0.009
-
Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort. J Acquir Immune Defic Syndr. 2017 05 01; 75(1):97-107.
Score: 0.009
-
Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study. J Int AIDS Soc. 2017 02 28; 20(1):21426.
Score: 0.009
-
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
Score: 0.003
-
Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy. Am J Hematol. 2021 08 01; 96(8):934-944.
Score: 0.003
-
Cyber harassment of female scientists will not be the new norm. Lancet Infect Dis. 2021 04; 21(4):457-458.
Score: 0.003
-
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study. Clin Infect Dis. 2020 05 23; 70(11):2369-2376.
Score: 0.003
-
Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort. Eur J Gastroenterol Hepatol. 2019 Nov; 31(11):1387-1396.
Score: 0.003
-
Chlamydia trachomatis screening in urine among asymptomatic men attending an STI clinic in Paris: a cross-sectional study. BMC Infect Dis. 2019 Jan 08; 19(1):31.
Score: 0.003
-
Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam. BMC Infect Dis. 2018 Dec 04; 18(1):622.
Score: 0.003
-
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study. Clin Infect Dis. 2018 09 14; 67(7):1010-1017.
Score: 0.003
-
Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals. AIDS. 2018 09 10; 32(14):1995-2004.
Score: 0.003
-
Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa. J Viral Hepat. 2018 10; 25(10):1121-1131.
Score: 0.003
-
CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2018 05; 34(5):439-445.
Score: 0.003
-
Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. Clin Infect Dis. 2018 01 06; 66(1):112-120.
Score: 0.002
-
Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study. Antivir Ther. 2018; 23(5):405-413.
Score: 0.002
-
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study). HIV Med. 2018 03; 19(3):227-237.
Score: 0.002
-
Low incidence of precore W28* mutant variants in treated hepatitis B virus and human immunodeficiency virus co-infected patients. Antiviral Res. 2018 01; 149:174-178.
Score: 0.002
-
Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients. AIDS. 2017 09 10; 31(14):1955-1964.
Score: 0.002
-
Diagnostic accuracy of the Coopscore© to predict liver fibrosis in human immunodeficiency virus/hepatitis B virus co-infection. Ann Clin Biochem. 2018 Mar; 55(2):236-243.
Score: 0.002
-
Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort. J Hepatol. 2017 07; 67(1):23-31.
Score: 0.002